Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2009-03-13

FDA Approved: EDLUAR — Original Application (Viatris Specialty LLC)

View source ↗

Summary

The FDA approved EDLUAR (zolpidem tartrate) through Viatris Specialty LLC's original NDA (NDA021997) for the treatment of insomnia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • EDLUAR (ZOLPIDEM TARTRATE)

Snippet

ORIG AP for EDLUAR (ZOLPIDEM TARTRATE)